Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
- PMID: 30352020
- DOI: 10.1515/hsz-2018-0204
Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
Abstract
Aberrant microglial activation and neuroinflammation is a pathological hallmark of amyotrophic lateral sclerosis (ALS). Fractalkine (CX3CL1) is mostly expressed on neuronal cells. The fractalkine receptor (CX3CR1) is predominantly expressed on microglia. Many progressive neuroinflammatory disorders show disruption of the CX3CL1/CX3CR1 communication system. But the exact role of the CX3CL1/CX3CR1 in ALS pathology remains unknown. F1 nontransgenic/CX3CR1+/- females were bred with SOD1G93A/CX3CR1+/- males to produce F2 SOD1G93A/CX3CR1-/-, SOD1G93A/CX3CR1+/+. We analyzed end-stage (ES) SOD1G93A/CX3CR1-/- mice and progression-matched SOD1G93A/CX3CR1+/+ mice. Our study showed that the male SOD1G93A/CX3CR1-/- mice died sooner than male SOD1G93A/CX3CR1+/+ mice. In SOD1G93A/CX3CR1-/- mice demonstrated more neuronal cell loss, more microglial activation and exacerbated SOD1 aggregation at the end-stage of ALS. The NF-κB pathway was activated; the autophagy-lysosome degradation pathway and the autophagosome maturation were impaired. Our results indicated that the absence of CX3CR1/CX3CL1 signaling in the central nervous system (CNS) may worsen neurodegeneration. The CX3CL1/CX3CR1 communication system has anti-inflammatory and neuroprotective effects and plays an important role in maintaining autophagy activity. This effort may lead to new therapeutic strategies for neuroprotection and provide a therapeutic target for ALS patients.
Keywords: CX3CR1; amyotrophic lateral sclerosis (ALS); autophagy; inflammatory.
Similar articles
-
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.Cells. 2020 Oct 13;9(10):2277. doi: 10.3390/cells9102277. Cells. 2020. PMID: 33065974 Free PMC article. Review.
-
Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.Brain Res Bull. 2019 Mar;146:12-21. doi: 10.1016/j.brainresbull.2018.11.017. Epub 2018 Nov 26. Brain Res Bull. 2019. PMID: 30496784 Review.
-
The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.Int J Mol Med. 2018 Jun;41(6):3577-3585. doi: 10.3892/ijmm.2018.3573. Epub 2018 Mar 16. Int J Mol Med. 2018. PMID: 29568873 Free PMC article.
-
Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model.Transl Neurodegener. 2018 Dec 21;7:35. doi: 10.1186/s40035-018-0138-4. eCollection 2018. Transl Neurodegener. 2018. PMID: 30607245 Free PMC article.
-
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases.Pharmacol Ther. 2022 Mar;231:107989. doi: 10.1016/j.pharmthera.2021.107989. Epub 2021 Sep 4. Pharmacol Ther. 2022. PMID: 34492237 Review.
Cited by
-
Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.J Neuroinflammation. 2021 Jun 15;18(1):139. doi: 10.1186/s12974-021-02191-2. J Neuroinflammation. 2021. PMID: 34130712 Free PMC article.
-
NLRP3 Inflammasome Is Involved in Cocaine-Mediated Potentiation on Behavioral Changes in CX3CR1-Deficient Mice.J Pers Med. 2021 Sep 27;11(10):963. doi: 10.3390/jpm11100963. J Pers Med. 2021. PMID: 34683104 Free PMC article.
-
Peripheral immune cell traits and Parkinson's disease: A Mendelian randomization study.PLoS One. 2024 Mar 5;19(3):e0299026. doi: 10.1371/journal.pone.0299026. eCollection 2024. PLoS One. 2024. PMID: 38442099 Free PMC article.
-
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.Cells. 2020 Oct 13;9(10):2277. doi: 10.3390/cells9102277. Cells. 2020. PMID: 33065974 Free PMC article. Review.
-
Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease.Neural Plast. 2023 Jan 4;2023:4637073. doi: 10.1155/2023/4637073. eCollection 2023. Neural Plast. 2023. PMID: 36644710 Free PMC article. Review.
References
-
- Bazan, J.F., Bacon, K.B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D.R., Zlotnik, A., and Schall, T.J. (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640–644.
-
- Bellingham, M.C. (2011). A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci. Ther. 17, 4–31.
-
- Boillee, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A., Kassiotis, G., Kollias, G., and Cleveland, D.W. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389–1392.
-
- Cardona, A.E., Pioro, E.P., Sasse, M.E., Kostenko, V., Cardona, S.M., Dijkstra, I.M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006). Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917–924.
-
- Cirulli, E.T., Lasseigne, B.N., Petrovski, S., Sapp, P.C., Dion, P.A., Leblond, C.S., Couthouis, J., Lu, Y.F., Wang, Q., Krueger, B.J., et al. (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436–1441.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous